An Overview of PARP Inhibitors in Ovarian Cancer

PARP Inhibitors in Ovarian Cancer Treatment: Understanding Side EffectsПодробнее

Advancing Therapeutic Paradigms for Ovarian Cancer in The Era of PARP Inhibitors: A Guide for The...Подробнее

Clinical Advances in Ovarian Cancer: Exploring the Expanding Role of PARP Inhibitors in the Treat...Подробнее

What Clinical Trials Are Recruiting for Recurrent Ovarian Cancer?Подробнее

PARP Inhibitor Maintenance in Newly Diagnosed Ovarian Cancer: Key Questions, Answers, and Insights Подробнее

Integrating New Research Information into Current Clinical Care — Ovarian CancerПодробнее

Let’s Talk Ovarian Cancer: Management of PARP Inhibitor Maintenance Treatment in PatientsПодробнее

PARP Inhibitors in the Management of Ovarian Cancer GuidelineПодробнее

Redefining Endometrial and Ovarian Carcinoma CareПодробнее

Episode 227: Biomarker Testing, PARP Inhibitors, and Oral Adherence During Ovarian Cancer Mainten...Подробнее

Ovarian Cancer and Tumor Treating Fields | Oncology Today with Dr Neil Love — Role of PARP Inhibi...Подробнее

What’s New with PARP Inhibitors and Ovarian Cancer?Подробнее

PARP inhibitor treatment in non-BRCA mutant high-grade serous ovarian cancer – Dr. Nicola HannawayПодробнее

HRD Testing in Ovarian Cancer - What Do You Need to Consider?Подробнее

Kick-Off & Ovarian Cancer OverviewПодробнее

Ask the Experts: HRD and GeneticsПодробнее

Upgrading the Treatment Algorithm for Advanced Ovarian CancerПодробнее

PARP inhibitors in ovarian cancer: Clinical updates from SGO 2023Подробнее

Webinar: Latest Developments in Ovarian Cancer 2023 (full)Подробнее

Webinar: Latest Developments in Ovarian Cancer 2023 - Associate Professor Yoland AntillПодробнее